GlassScriptPhysician profile
Nancy J Short
NPI 1134125032
$1,625.03
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $183 · 2021: $292 · 2022: $429 · 2023: $235 · 2024: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $339.94 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $328.65 | 2019-2024 | Farxiga, Airsupra |
| Pfizer INC. | $137.92 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $110.67 | 2019-2021 | |
| Abbvie INC. | $110.25 | 2019-2022 | |
| Medtronic, INC. | $81.14 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $69.08 | 2019-2022 | |
| Lilly USA, LLC | $62.71 | 2020-2023 | Jardiance, Emgality |
| Amgen INC. | $59.69 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.45 | 2021-2024 | Jardiance |
| Amarin Pharma, INC. | $49.27 | 2021-2022 | |
| Glaxosmithkline, LLC. | $47.04 | 2020-2023 | Trelegy Ellipta |
| Esperion Therapeutics, INC. | $28.80 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.65 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.58 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.22 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.92 | 2023 | Eliquis |
| Allergan, INC. | $17.66 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $17.19 | 2023 | Jynarque |
| Kiniksa Pharmaceuticals, LTD. | $13.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Short listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.